Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Aug;90(8):1034-9.
doi: 10.1136/bjo.2006.090852. Epub 2006 Apr 13.

Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranes

Affiliations

Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranes

K Petermeier et al. Br J Ophthalmol. 2006 Aug.

Abstract

Aim: To evaluate the impact of verteporfin photodynamic therapy (PDT) on the induction of apoptosis in choroidal neovascular membranes (CNV) secondary to age related macular degeneration.

Methods: Retrospective review of 22 surgically excised CNV. 12 of these patients had been treated with PDT 3-146 days previously. Apoptotic cells were detected with the TUNEL technique and compared to the expression of CD34 (endothelial cells, EC), CD105 (activated endothelial cells), Ki-67 (proliferation marker), and cytokeratin18 (retinal pigment epithelial cells, RPE).

Results: CNV excised 3 days after PDT were characterised both by collapsed and patent vessels. The EC displayed a statistical significant positive TUNEL reaction when compared to the remaining treated CNV (p < 0.001) and untreated CNV (P = 0.002). The proliferative activity was reduced. CNV excised 1-5 months after PDT displayed a patent vascularisation and high proliferative activity. All membranes either treated or untreated disclosed only sporadic TUNEL positive cells within the stroma and the RPE.

Conclusions: Verteporfin PDT leads to selective and effective damage of EC within CNV. Both patent and occluded vessels were lined by apoptotic EC. This finding and the increased expression of proliferation marker at later time points suggest that revascularisation after PDT is caused by angiogenesis rather than recanalisation.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests related to the manuscript.

References

    1. Ambati J, Ambati B K, Yoo S H.et al Age‐related macular degeneration: etiology, pathogenesis and therapeutic strategies. Surv Ophthalmol 200348257–293. - PubMed
    1. Treatment of Age‐Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age‐related macular degeneration with verteporfin: one‐year results of 2 randomized clinical trials—TAP Report 1. Arch Ophthalmol 19991171329–1345. - PubMed
    1. Treatment of Age‐Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age‐related macular degeneration with verteporfin: two‐year results of 2 randomized clinical trials—TAP Report 2. Arch Ophthalmol 2001119198–207. - PubMed
    1. Treatment of Age‐Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Verteporfin therapy of subfoveal choroidal neovascularization in patients with age‐related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes—TAP Report No 3. Arch Ophthalmol 20021201443–1454. - PubMed
    1. Verteporfin in Photodynamic Therapy Study group Verteporfin therapy of subfoveal choroidal neovascularization in age‐related macular degeneration: two‐year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—Verteporfin in Photodynamic Therapy report 2. Am J Ophthalmol 2001131541–560. - PubMed

Publication types

MeSH terms